Graduate studies at Western
Neuroethics 5 (2):173-184 (2012)
|Abstract||Over the past few years the use of stimulants such as methylphenidate and modafinil among the student population has attracted considerable debate in the pages of bioethics journals. Under the rubric of cognitive enhancement, bioethicists have discussed this use of stimulants—along with future technologies of enhancement—and have launched a sometimes forceful debate of such practices. In the following paper, it is argued that even if we focus solely upon current practices, the term cognitive enhancement encompasses a wide range of ethical considerations that can usefully be addressed without the need for speculation. In taking this position it is suggested that we divide cognitive enhancement into a series of empirically-constructed frameworks—medical risks and benefits, self-medication and under-prescription, prescription drug abuse and over-medication, and finally, the intention to cognitively enhance. These are not mutually exclusive frameworks, but provide a way in which to identify the scope of the issue at hand and particular ethical and medical questions that may be relevant to enhancement. By a process of elimination it is suggested that we can indeed talk of cognitive enhancement as an observable set of practices. However, in doing so we should be aware of how academic commentaries and discussion may be seen as both capturing reality and reifying cognitive enhancement as an entity|
|Keywords||Bioethics Cognitive enhancement Framing Stimulants|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Nick Bostrom (2009). Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. [REVIEW] Science and Engineering Ethics 15 (3):311-341.
Stephanie Bell, Brad Partridge, Jayne Lucke & Wayne Hall (2013). Australian University Students' Attitudes Towards the Acceptability and Regulation of Pharmaceuticals to Improve Academic Performance. Neuroethics 6 (1):197-205.
John Harris (2011). Moral Enhancement and Freedom. Bioethics 25 (2):102-111.
S. M. Outram & E. Racine (2011). Developing Public Health Approaches to Cognitive Enhancement: An Analysis of Current Reports. Public Health Ethics 4 (1):93-105.
Arianna Ferrari, Christopher Coenen & Armin Grunwald (2012). Visions and Ethics in Current Discourse on Human Enhancement. Nanoethics 6 (3):215-229.
Eric Racine & Cynthia Forlini (2010). Cognitive Enhancement, Lifestyle Choice or Misuse of Prescription Drugs? Neuroethics 3 (1):1-4.
Lubomira Radoilska (2010). An Aristotelian Approach to Cognitive Enhancement. Journal of Value Inquiry 44 (3):365–375.
Danielle C. Turner & Barbara J. Sahakian (2006). Ethical Questions in Functional Neuroimaging and Cognitive Enhancement. Poiesis and Praxis 4 (2):81-94.
Jonathan Wolff (2009). Cognitive Disability in a Society of Equals. Metaphilosophy 40 (3-4):402-415.
Katherine Drabiak-Syed (2011). Reining In the Pharmacological Enhancement Train: We Should Remain Vigilant About Regulatory Standards for Prescribing Controlled Substances. Journal of Law, Medicine and Ethics 39 (2):272-279.
Allen Buchanan (2008). Enhancement and the Ethics of Development. Kennedy Institute of Ethics Journal 18 (1):pp. 1-34.
Maartje Schermer, Ineke Bolt, Reinoud de Jongh & Berend Olivier (2009). The Future of Psychopharmacological Enhancements: Expectations and Policies. Neuroethics 2 (2):75-87.
Danielle C. Turner & Barbara J. Sahakian (2006). Neuroethics of Cognitive Enhancement. 1 (1):113--123.
Rebecca Roache & Steve Clarke (2009). Bioconservatism, Bioliberalism, and Repugnance. Monash Bioethics Review 28 (1):04.1-04.21.
Added to index2011-07-07
Total downloads39 ( #34,943 of 751,991 )
Recent downloads (6 months)2 ( #38,076 of 751,991 )
How can I increase my downloads?